Marcus A Mall Selected Research

Inborn Genetic Diseases (Disease, Hereditary)

1/2018	Ion Channel Modulators in Cystic Fibrosis.
1/2016	Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
2/2009	Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus A Mall Research Topics

Disease

100	Cystic Fibrosis (Mucoviscidosis) 03/2024 - 02/2009
53	Lung Diseases (Lung Disease) 11/2023 - 12/2008
38	Inflammation (Inflammations) 03/2024 - 03/2008
15	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 04/2008
15	Infections 08/2023 - 01/2012
12	COVID-19 03/2024 - 08/2020
11	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023 - 01/2016
9	Asthma (Bronchial Asthma) 01/2022 - 01/2011
8	Pneumonia (Pneumonitis) 12/2022 - 01/2012
7	Metaplasia 07/2017 - 03/2008
6	Bronchiectasis 09/2023 - 01/2018
6	Emphysema 01/2023 - 05/2014
5	Bacterial Infections (Bacterial Infection) 12/2023 - 05/2014
5	Necrosis 01/2020 - 12/2008
5	Dehydration (Water Stress) 01/2016 - 04/2009
4	Fibrosis (Cirrhosis) 01/2022 - 10/2017
3	Rare Diseases (Rare Disease) 10/2023 - 07/2022
3	Persistent Infection 08/2023 - 01/2020
3	Disease Progression 01/2023 - 08/2020
3	Eosinophilia 01/2020 - 04/2009
3	Chronic Disease (Chronic Diseases) 01/2020 - 12/2008
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2018 - 02/2009
2	Rhinosinusitis 01/2024 - 01/2021
2	Drug Hypersensitivity (Drug Allergy) 12/2023 - 01/2021
2	Neoplasms (Cancer) 11/2022 - 01/2017
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 07/2022 - 11/2018
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022 - 01/2021
2	Idiopathic Pulmonary Fibrosis 06/2021 - 10/2017
2	Airway Remodeling 01/2015 - 12/2008
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023
1	Airway Obstruction (Choking) 12/2023
1	Hypersensitivity (Allergy) 12/2023

Drug/Important Bio-Agent (IBA)

28	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2023 - 02/2009
21	elexacaftorIBA 03/2024 - 10/2018
20	ivacaftor drug combination tezacaftorIBA 03/2024 - 10/2018
13	ChloridesIBA 12/2023 - 10/2012
12	ivacaftorIBA 01/2024 - 11/2015
11	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2009
10	MucinsIBA 01/2023 - 04/2008
9	lumacaftorIBA 01/2024 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2011
7	Leukocyte Elastase (Neutrophil Elastase)IBA 11/2022 - 05/2014
7	Peptide Hydrolases (Proteases)FDA Link 05/2021 - 02/2014
6	SmokeIBA 12/2023 - 11/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 03/2016
6	CytokinesIBA 12/2021 - 04/2008
5	Pancreatic Elastase (Elastase)IBA 01/2023 - 01/2018
5	Interleukin-1 (Interleukin 1)IBA 01/2022 - 01/2017
5	Epithelial Sodium ChannelsIBA 01/2022 - 09/2015
5	Interleukin-8 (Interleukin 8)IBA 09/2021 - 11/2015
5	Chloride Channels (Chloride Channel)IBA 01/2018 - 07/2012
4	InterleukinsIBA 01/2022 - 11/2015
4	AntibodiesIBA 10/2021 - 11/2012
4	Immunoglobulin G (IgG)IBA 10/2021 - 01/2021
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 04/2015
4	Interleukin-13IBA 07/2017 - 04/2008
4	Amiloride (Midamor)FDA LinkGeneric 07/2017 - 12/2008
4	ChitinasesIBA 12/2015 - 04/2008
3	LipidsIBA 11/2023 - 01/2015
3	NitrogenIBA 06/2023 - 01/2020
3	tezacaftorIBA 01/2023 - 11/2019
3	Ion Channels (Ion Channel)IBA 01/2022 - 09/2015
3	Chemotactic FactorsIBA 01/2022 - 09/2013
3	Messenger RNA (mRNA)IBA 10/2021 - 11/2015
3	cathepsin SIBA 01/2021 - 07/2014
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2010
3	AllergensIBA 01/2020 - 01/2017
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 04/2015
3	AnionsIBA 04/2019 - 11/2015
3	IronIBA 06/2017 - 01/2012
3	LipopolysaccharidesIBA 11/2015 - 01/2012
2	Expectorants (Mucolytics)IBA 01/2023 - 01/2020
2	Therapeutic UsesIBA 01/2023 - 12/2008
2	ProteomeIBA 01/2023 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 11/2022 - 09/2009
2	EnzymesIBA 11/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2021
2	GlucocorticoidsIBA 01/2022 - 04/2009
2	Peptides (Polypeptides)IBA 01/2022 - 10/2021
2	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 05/2021 - 01/2016
2	Vitamin A (Retinol)FDA LinkGeneric 03/2021 - 01/2015
2	VitaminsIBA 03/2021 - 01/2015
2	Serine Proteases (Serine Protease)IBA 01/2021 - 03/2019
2	Matrix Metalloproteinase 12IBA 12/2016 - 11/2014
2	TrypsinogenIBA 11/2016 - 10/2010
2	Pancreatitis-Associated ProteinsIBA 11/2016 - 10/2010
2	MicroRNAs (MicroRNA)IBA 12/2015 - 11/2015
2	GoldIBA 07/2014 - 05/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 04/2008
1	VaccinesIBA 03/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2024
1	Meropenem (Merrem)FDA LinkGeneric 12/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 12/2023
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2023
1	resolvin D1IBA 11/2023
1	ChemokinesIBA 11/2023
1	SugarsIBA 11/2023

Therapy/Procedure

46	Therapeutics 01/2024 - 04/2008
3	Fluid Therapy (Oral Rehydration Therapy) 07/2014 - 09/2013